These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6825828)

  • 1. [Effect of pentoxifylline on the dissociation curve of oxyhemoglobin].
    Grandillo F; Giunta R; Scognamiglio G; Tirelli A; Coppola L; Torella R
    Farmaco Sci; 1983 Jan; 38(1):29-34. PubMed ID: 6825828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
    Chmiel H; Anadere I; Heimburg P
    Ric Clin Lab; 1981; 11 Suppl 1():189-96. PubMed ID: 7188108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
    Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Angelkort B; Maurin N; Boateng K
    Curr Med Res Opin; 1979; 6(4):255-8. PubMed ID: 527350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects on hemoglobin-oxygen affinity in vitro and in patients with chronic obstructive pulmonary disease.
    Kishi F; Nishiura Y; Kamada A; Kawakami Y
    Adv Exp Med Biol; 1988; 222():341-7. PubMed ID: 3129913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical results of pentoxifylline use in a community peripheral vascular surgical practice.
    Smith MA; Fish RC
    Monogr Atheroscler; 1990; 15():27-9. PubMed ID: 2296248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of hyperoxia on the oxyhemoglobin dissociation curve in various periods of aging].
    Ivanov LA; Chebotarev ND
    Biull Eksp Biol Med; 1984 Aug; 98(8):156-8. PubMed ID: 6466848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of pentoxiphylline on oxygen transport during hypothermia.
    Hershenson MB; Schena JA; Lozano PA; Jacobson MJ; Crone RK
    J Appl Physiol (1985); 1989 Jan; 66(1):96-101. PubMed ID: 2917962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].
    Pupita F; Rotatori P; Frausini G
    Ric Clin Lab; 1981; 11 Suppl 1():293-302. PubMed ID: 7188116
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
    Zaccaria A; Antonini M; Marciani A; Taurino M; Speziale F; Spartera C
    Ric Clin Lab; 1981; 11 Suppl 1():381-6. PubMed ID: 7188126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
    Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ; Rössner M
    Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pentoxifylline on platelet aggregation.
    Nenci GG; Gresele P; Agnelli G; Ballatori E
    Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of arterial diseases. A study with Trental 400].
    Tannenberg G
    Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Worsening of arterial occlusive diseases by pentoxifylline?].
    Schoop W
    Dtsch Med Wochenschr; 1980 Jan; 105(4):114. PubMed ID: 7351191
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease.
    Hartmann A
    Pharmatherapeutica; 1981; 2(8):528-31. PubMed ID: 7255509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.